Drug reference

urapidil

α1 receptor antagonist · Antihypertensive, Alpha Blocker

α1 receptor antagonistAntihypertensive, Alpha BlockerATC C02CA06

CDSCO approvedATC C02CA06

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Urapidil is a selective α1 receptor antagonist that causes hypotension primarily through peripheral α1 adrenergic receptor blockade, but also has CNS actions.

Related guidelines

Beta-blockers in hypertension

MOHFW · Cardiology · 2024

Benign prostatic hyperplasia

AUA · Urology · 2018

Hypertension in adults

WHO · Cardiology · 2021

Hypertension in adults

ICMR · Cardiology · 2019

Ask House about urapidil

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team